Welcome to our dedicated page for Suzano S.A. SEC filings (Ticker: SUZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Suzano S.A.'s SEC filings document its status as a Brazilian foreign private issuer with American depositary shares listed on the NYSE and ordinary shares traded on B3. Annual Form 20-F reporting and Form 6-K current reports cover consolidated pulp, paper and packaging results, IFRS financial statements, operating metrics, debt, leverage, cash generation and risk disclosures for an integrated forestry-based producer.
The filing record also includes bylaws, board and shareholder meeting minutes, dividend notices, financing disclosures involving rural product notes and debentures, and governance materials tied to the company's authorized-capital structure and Novo Mercado listing obligations. These documents provide formal disclosure on capital structure, shareholder approvals, corporate governance and material operating updates.
Suzano S.A. furnished its audited consolidated financial statements for the year ended December 31, 2025, showing a strong rebound in performance. Net sales reached R$50,115,679 thousand, up from R$47,403,282 thousand in 2024, and net income swung to a profit of R$13,437,687 thousand from a loss of R$(7,044,706) thousand.
Operating profit before net financial items was R$10,649,009 thousand, supported by significant gains from derivative financial instruments and favorable monetary and exchange variations. Cash provided by operating activities was R$18,152,175 thousand, funding heavy investments in property, plant, equipment and biological assets.
The company highlighted a planned acquisition by its subsidiary of a 51% interest in a global tissue business carved out from Kimberly-Clark for US$1,734 billion (about R$9,541 billions), expected to close by mid‑2026, and a share capital increase of R$5,000,000 thousand via reserve capitalization. Interim dividends of R$1,380,000 thousand were approved. Management concluded that internal control over financial reporting was effective as of December 31, 2025, and PricewaterhouseCoopers issued unqualified opinions on both the financial statements and internal controls, while identifying critical audit matters on biological asset valuation and tax and social security litigation.
Suzano S.A. announced that its Board of Directors approved a new share buyback plan, called the February/2026 Program, allowing the company to repurchase up to 40,000,000 of its own common shares, about 6.5% of its current free float of 612,918,471 shares.
These purchases may be made on B3 at market prices over an 18‑month period from February 10, 2026 to August 10, 2027. Suzano plans to fund the buybacks using available profits and capital reserves, as well as realized profit for the year, and the Board believes the company’s financial position supports the program without affecting debt obligations or mandatory dividends.
Suzano S.A. has completed its share buyback program that began on August 9, 2024 and was approved by the Board of Directors. Under this program, the company acquired 14,820,500 common shares in stock exchange regular trading sessions at an average price of R$54.33 per share, for a total of R$805 million.
After these acquisitions, Suzano now holds 28,020,765 common shares in treasury. The company communicated this conclusion to shareholders and the market through this notice.
Suzano S.A. reported that its Board of Directors approved the renewal and contracting of an international revolving credit facility of up to US$ 1,800,000,000.00. The facility has an initial term of five years and may be extended twice, for one year per extension request.
The credit line will be contracted by wholly owned subsidiary Suzano International Finance B.V., or another subsidiary, with certain financial institutions abroad. Suzano will provide a guarantee for all obligations under the facility and authorized its Vice-Presidency to enter into related hedging derivatives that do not allow risk leverage.
Suzano S.A. entered into a new stand-by revolving credit facility through its wholly owned subsidiary Suzano International Finance B.V., replacing a facility in place since February 2022. The total stand-by credit capacity rises from US$ 1,275 million to US$ 1,775 million.
The new stand-by facility is available until February 2031, supporting liquidity and cash management over the coming years. Suzano will pay a 0.27% per annum commitment fee on any unused portion, and any drawn amount will bear interest at SOFR + 0.90% per annum.
Suzano S.A., a foreign private issuer, submitted a Form 6-K for December 2025. The filing notes that the company reports under Form 20-F and includes a single enclosure identified as Exhibit 99.1 – Shareholder's Agreement. The report is signed on behalf of Suzano S.A. by Marcos Moreno Chagas Assumpção, Vice-President of Finance and Investor Relations.